Around the Nation: Minnesota just passed a bill to ban vaping in most public places

Bite-sized hospital and health care news

 The bill would prohibit vaping in most public buildings, workplaces, and restaurants in the state, as well as on public transportation, in today's bite-sized hospital and health industry news from Indiana, Massachusetts, and Minnesota.
  • Indiana: The NeuroDiagnostic Institute (NDI) will replace LaRue D. Carter Memorial Hospital as Central Indiana's psychiatric hospital. The new $118 million facility will operate as the focal diagnostic center for Indiana's six mental health facilities, which will all share the same EHR system. NDI will be the main site for psychiatric patients with complicated diagnoses (Rudavsky, Indianapolis Star, 3/14).

  • Massachusetts: Harvard University just received $100 million from health care hedge fund Deerfield Management as part of a new drug research partnership. The funds will allow the organizations to establish and jointly operate Lab1636, a company that will "offer sustained support to ensure breakthrough innovations," according to Isaac Kohlberg, senior associate provost and chief technology development officer at Harvard (Paavola, Becker’s Hospital Review, 3/14).

  • Minnesota: The Minnesota House on Thursday passed a bill that would ban vaping in the same places that tobacco smoking is banned under the Minnesota Clean Indoor Air Act. The bill would prohibit the use of e-cigarettes and other vaping devices in most public buildings, workplaces, and restaurants in the state, as well as on public transportation. State Rep. Laurie Halverson (D), chief author of the bill, said she hopes the bill will allow the state to crack down on the "epidemic of youth smoking" (Karnowski, Sacramento Bee, 3/14).

Next, learn how to expand your lung cancer screening program

Ten million individuals nationwide are eligible for lung screening every year—but the average program only screens about 25. Given its potential to increase survival and volumes, lung cancer screening is one of the best opportunities to achieve program cost, quality, and growth goals.

Early adopters, however, are finding it challenging to market the program to patients and primary care providers. Download this infographic to learn how to reach them—and grow your screening program.

Download the Infographic


Next in the Daily Briefing

How Civica Rx—the hospital-led generic drug venture—will 'shake up' the marketplace, according to Intermountain's Marc Harrison

Read now